Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

Related Articles by Review for PubMed (Select 17184992)

1.

Molecular chaperones and protein kinase quality control.

Caplan AJ, Mandal AK, Theodoraki MA.

Trends Cell Biol. 2007 Feb;17(2):87-92. Epub 2006 Dec 20. Review.

PMID:
17184992
2.

[Molecular chaperone HSP90 as a novel target for cancer chemotherapy].

Miyata Y.

Nihon Yakurigaku Zasshi. 2003 Jan;121(1):33-42. Review. Japanese.

PMID:
12617036
3.

Protein kinase CK2 in health and disease: CK2: the kinase controlling the Hsp90 chaperone machinery.

Miyata Y.

Cell Mol Life Sci. 2009 Jun;66(11-12):1840-9. doi: 10.1007/s00018-009-9152-0. Review.

PMID:
19387550
4.

A model for the cytoplasmic trafficking of signalling proteins involving the hsp90-binding immunophilins and p50cdc37.

Pratt WB, Silverstein AM, Galigniana MD.

Cell Signal. 1999 Dec;11(12):839-51. Review.

PMID:
10659992
5.

Hsp90 and Cdc37 -- a chaperone cancer conspiracy.

Pearl LH.

Curr Opin Genet Dev. 2005 Feb;15(1):55-61. Review.

PMID:
15661534
6.

[Involvement of Hsp90 in the quality control of signal transducing proteins].

Miyata Y.

Tanpakushitsu Kakusan Koso. 2004 May;49(7 Suppl):862-6. Review. Japanese. No abstract available.

PMID:
15168480
7.

Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 N-terminal ATP binding site.

Hadden MK, Lubbers DJ, Blagg BS.

Curr Top Med Chem. 2006;6(11):1173-82. Review.

PMID:
16842154
8.

Structure and in vivo function of Hsp90.

Pearl LH, Prodromou C.

Curr Opin Struct Biol. 2000 Feb;10(1):46-51. Review.

PMID:
10679459
9.

The Hsp90 molecular chaperone: an open and shut case for treatment.

Pearl LH, Prodromou C, Workman P.

Biochem J. 2008 Mar 15;410(3):439-53. doi: 10.1042/BJ20071640. Review.

PMID:
18290764
10.

Inhibition of Hsp90: a new strategy for inhibiting protein kinases.

Sreedhar AS, Soti C, Csermely P.

Biochim Biophys Acta. 2004 Mar 11;1697(1-2):233-42. Review.

PMID:
15023364
11.

Constantly updated knowledge of Hsp90.

Terasawa K, Minami M, Minami Y.

J Biochem. 2005 Apr;137(4):443-7. Review.

PMID:
15858167
12.

Cdc37 goes beyond Hsp90 and kinases.

MacLean M, Picard D.

Cell Stress Chaperones. 2003 Summer;8(2):114-9. Review.

13.
14.

Hsp90: chaperoning signal transduction.

Richter K, Buchner J.

J Cell Physiol. 2001 Sep;188(3):281-90. Review.

PMID:
11473354
15.

Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.

Chiosis G, Caldas Lopes E, Solit D.

Curr Opin Investig Drugs. 2006 Jun;7(6):534-41. Review.

PMID:
16784024
16.

Hsp70 and Hsp90--a relay team for protein folding.

Wegele H, Müller L, Buchner J.

Rev Physiol Biochem Pharmacol. 2004;151:1-44. Epub 2004 Jan 23. Review.

PMID:
14740253
17.
18.

Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex.

Stravopodis DJ, Margaritis LH, Voutsinas GE.

Curr Med Chem. 2007;14(29):3122-38. Review.

PMID:
18220746
19.

Hsp90 & Co. - a holding for folding.

Buchner J.

Trends Biochem Sci. 1999 Apr;24(4):136-41. Review.

PMID:
10322418
20.

The Hsp90 complex--a super-chaperone machine as a novel drug target.

Scheibel T, Buchner J.

Biochem Pharmacol. 1998 Sep 15;56(6):675-82. Review.

PMID:
9751071
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk